Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.
K E Balashov, … , D A Hafler, H L Weiner
K E Balashov, … , D A Hafler, H L Weiner
Published June 1, 1995
Citation Information: J Clin Invest. 1995;95(6):2711-2719. https://doi.org/10.1172/JCI117973.
View: Text | PDF
Research Article Article has an altmetric score of 8

Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.

  • Text
  • PDF
Abstract

The autologous mixed lymphocyte reaction (AMLR) involves the activation of T cells by autologous antigen presenting cells. Cells are generated during the course of the AMLR that have suppressive properties in vitro. In the present study we investigated the induction of CD8+ T cells in the AMLR with suppressive properties and the mechanism by which these cells downregulate in vitro proliferative responses. Purified CD8+ but not CD4+ T cells activated in the AMLR in conditioned medium inhibited proliferation of autologous T cells by anti-CD3 or PPD. Nonactivated CD8+ T cells did not suppress. The CD8+ T cells activated in the AMLR in the presence of conditioned medium (CD8+ Tact) were CD11b negative and were noncytotoxic. The inhibitory effect of CD8+ Tact cells was completely abrogated by anti-IFN-gamma antibody, but not by anti-IL-4, anti-IL-10, or anti-TGF-beta antibody. The induction of CD8+ Tact cells in the AMLR was blocked by anti-IL-2 or by anti-GM-CSF antibody and the combination of these two recombinant cytokines could support the induction of suppressive CD8+ Tact cells. CD8+ Tact cells were defective in patients with chronic progressive multiple sclerosis (MS) as compared to patients with relapsing-remitting MS or normal controls. Our studies provide a basis for understanding the mechanism of suppression by human CD8+ T cells in terms of specific cytokines, and demonstrate the potential importance of these cells in a human autoimmune disease as their function is defective in patients with progressive MS.

Authors

K E Balashov, S J Khoury, D A Hafler, H L Weiner

×

Total citations by year

Year: 2023 2020 2019 2018 2017 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1997 1996 Total
Citations: 1 2 6 2 4 3 3 1 3 4 3 7 9 5 8 6 2 2 4 5 1 5 5 2 93
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (93)

Title and authors Publication Year
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Charabati M, Wheeler MA, Weiner HL, Quintana FJ
Cell 2023
IL-12-Induced Immune Suppressive Deficit During CD8+ T-Cell Differentiation
PS Renavikar, S Sinha, AA Brate, N Borcherding, MP Crawford, SM Steward-Tharp, NJ Karandikar
Frontiers in immunology 2020
CD8+ T cells: The past and future of immune regulation
JR Lees
Cellular Immunology 2020
Future prospects for CD8 + regulatory T cells in immune tolerance
L Flippe, S Bézie, I Anegon, C Guillonneau
Immunological Reviews 2019
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
LV Kaer, JL Postoak, C Wang, G Yang, L Wu
Cellular and Molecular Immunology 2019
Immunometabolism: A new target for improving cancer immunotherapy
Guo C, Chen S, Liu W, Ma Y, Li J, Fisher PB, Fang X, Wang XY
Advances in cancer research 2019
Co-stimulatory and co-inhibitory pathways in cancer immunotherapy
O\u2019Neill RE, Cao X
Advances in cancer research 2019
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR
Advances in cancer research 2019
The expanding family of noncanonical regulatory cell subsets
H Zhao, R Feng, A Peng, G Li, L Zhou
Journal of leukocyte biology 2019
Description of CD8 + Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer
MR Vieyra-Lobato, J Vela-Ojeda, L Montiel-Cervantes, R López-Santiago, MC Moreno-Lafont
Journal of Immunology Research 2018
IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells
J Plaumann, M Engelhardt, MH Awwad, H Echchannaoui, E Amman, MS Raab, J Hillengass, N Halama, B Neuber, C Müller-Tidow, H Goldschmidt, M Hundemer
Cancer Immunology, Immunotherapy 2018
Molecular mechanisms underlying Th1-like Treg generation and function
A Kitz, M Dominguez-Villar
Cellular and Molecular Life Sciences 2017
Memory CD4(+) T cells are suppressed by CD8(+) regulatory T cells in vitro and in vivo
Xin Long, Qi Cheng, Huifang Liang, Jianping Zhao, Jian Wang, Wei Wang, Stephen Tomlinson, Lin Chen, Carl Atkinson, Bixiang Zhang, Xiaoping Chen, Peng Zhu
American journal of translational research 2017
Functional properties of peripheral CD8 +  T cells in patients with repeated implantation failure
B Yin, Y Zeng, T Wu, S Yu, J Xu, S Liu, L Diao, Z Zhao, D Liang, Y Li
American Journal of Reproductive Immunology 2017
The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)
C Bolton, PA Smith
Ageing Research Reviews 2017
Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
G Arellano, PA Ottum, LI Reyes, PI Burgos, R Naves
Frontiers in immunology 2015
CD8+ T-Cells as Immune Regulators of Multiple Sclerosis
S Sinha, AW Boyden, FR Itani, MP Crawford, NJ Karandikar
Frontiers in immunology 2015
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 – 2014)
AM Papini, E König
Expert Opinion on Therapeutic Patents 2015
Immune regulation of multiple sclerosis by CD8+ T cells
S Sinha, FR Itani, NJ Karandikar
Immunologic Research 2014
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells
K Cunnusamy, EJ Baughman, J Franco, SB Ortega, S Sinha, P Chaudhary, BM Greenberg, EM Frohman, NJ Karandikar
Clinical Immunology 2014
A high frequency of peripheral blood NKG2D+NK and NKT cells in euthyroid patients with new onset hashimoto’s thyroiditis—a pilot study
H Guo, B Xu, X Yang, Y Wang, X Liu, C Cui, Y Jiang
Immunological Investigations 2014
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis
YA Levy, KM Fainberg, T Amidror, K Regev, E Auriel, A Karni
Journal of Neuroimmunology 2013
Working out mechanisms of controlled/physiologic inflammation in the GI tract
K Rabinowitz, L Mayer
Immunologic Research 2012
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients
P Quaglino, E Antiga, A Comessatti, M Caproni, T Nardò, R Ponti, M Novelli, S Osella-Abate, P Fabbri, MG Bernengo
Archives of Dermatological Research 2012
Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells
I Traverso, D Fenoglio, S Negrini, A Parodi, F Battaglia, F Kalli, G Conteduca, S Tardito, P Traverso, F Indiveri, G Filaci
Human Immunology 2012
Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes
EB Remmerswaal, SH Havenith, MM Idu, EM van Leeuwen, KA van Donselaar, A Brinke, N der Bom-Baylon, FJ Bemelman, RA van Lier, IJ Berge
Blood 2011
CD8+ Tregs in autoimmunity: learning “self”-control from experience
S Tsai, X Clemente-Casares, P Santamaria
Cellular and Molecular Life Sciences 2011
Reduced ErbB4 Expression in Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis
E Tynyakov-Samra, E Auriel, Y Levy-Amir, A Karni
Multiple Sclerosis International 2011
Reduced production of noggin by immune cells of patients with relapsing–remitting multiple sclerosis
N Urshansky, K Mausner-Fainberg, E Auriel, K Regev, NM Bornstein, A Karni
Journal of Neuroimmunology 2011
Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis
NR York, JP Mendoza, SB Ortega, A Benagh, AF Tyler, M Firan, NJ Karandikar
Journal of Autoimmunity 2010
CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity
G Filaci, D Fenoglio, F Indiveri
Autoimmunity 2010
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm
H Batoulis, K Addicks, S Kuerten
Annals of Anatomy - Anatomischer Anzeiger 2010
Novel CD8+Treg suppress EAE by TGF-β- and IFN-γ-dependent mechanisms
ML Chen, BS Yan, D Kozoriz, HL Weiner
European Journal of Immunology 2009
Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells
J Zheng, Y Liu, G Qin, PL Chan, H Mao, KT Lam, DB Lewis, YL Lau, W Tu
Journal of immunology (Baltimore, Md. : 1950) 2009
Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects
HI Cho, E Celis
Cancer research 2009
Changes in T cell phenotype and activated MAPKs are correlated to impaired cellular responses to antigens and glucocorticoids during HTLV-I infection
MM Pillat, BL Correa, CF da Rocha, GC Müller, RP Lopes, SS Lampert, AL Teixeira, M Menna-Barreto, ME Bauer
Journal of Neuroimmunology 2009
Regulatory T Cell (Treg) Subsets Return in Patients with Refractory Lupus following Stem Cell Transplantation, and TGF-β-Producing CD8 + Treg Cells Are Associated with Immunological Remission of Lupus
L Zhang, AM Bertucci, R Ramsey-Goldman, RK Burt, SK Datta
Journal of immunology (Baltimore, Md. : 1950) 2009
TGF-beta and IL-10 production by HIV-specific CD8+ T cells is regulated by CTLA-4 signaling on CD4+ T cells
M Elrefaei, CM Burke, CA Baker, NG Jones, S Bousheri, DR Bangsberg, H Cao
PloS one 2009
Handbook on Immunosenescence
T Fulop, C Franceschi, K Hirokawa, G Pawelec
2009
Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection
D Azoulay, N Urshansky, A Karni
Journal of Neuroimmunology 2008
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice
BJ Skaggs, RP Singh, BH Hahn
Human Immunology 2008
Revival of CD8+ Treg–mediated suppression
TR Smith, V Kumar
Trends in Immunology 2008
The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation
AL Zozulya, H Wiendl
Human Immunology 2008
Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3γ1(Ala-Ala)
V Ablamunits, KC Herold
Human Immunology 2008
Alloantigen-induced regulatory CD8+CD103+ T cells
SD Koch, E Uss, RA van Lier, IJ Berge
Human Immunology 2008
Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barré syndrome patients compared to controls
J Harness, PA McCombe
Journal of Clinical Neuroscience 2008
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells
D Fenoglio, F Ferrera, M Fravega, P Balestra, F Battaglia, M Proietti, C Andrei, D Olive, LC Antonio, F Indiveri, G Filaci
Human Immunology 2008
CD8 + CD28 − , suppressive T cells in systemic lupus erythematosus
A Tulunay, S Yavuz, H Direskeneli, E Eksioglu-Demiralp
Lupus 2008
CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFNgamma and indoleamine 2,3 dioxygenase
Carole Guillonneau, Marcelo Hill, François-Xavier Hubert, Elise Chiffoleau, Caroline Hervé, Xian-Liang Li, Michèle Heslan, Claire Usal, Laurent Tesson, Séverine Ménoret, Abdelhadi Saoudi, Régis Josien, Maria Cristina Cuturi, Ignacio Anegon
Journal of Clinical Investigation 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers
G Filaci, D Fenoglio, M Fravega, G Ansaldo, G Borgonovo, P Traverso, B Villaggio, A Ferrera, A Kunkl, M Rizzi, F Ferrera, P Balestra, M Ghio, P Contini, M Setti, D Olive, B Azzarone, G Carmignani, JL Ravetti, G Torre, F Indiveri
Journal of immunology (Baltimore, Md. : 1950) 2007
HIV-Specific IL-10-Positive CD8 + T Cells Suppress Cytolysis and IL-2 Production by CD8 + T Cells
M Elrefaei, FL Ventura, CA Baker, R Clark, DR Bangsberg, H Cao
Journal of immunology (Baltimore, Md. : 1950) 2007
CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis
S Jilek, M Schluep, AO Rossetti, L Guignard, GL Goff, G Pantaleo, RA du Pasquier
Clinical Immunology 2007
Long-Term Staphylococcal Enterotoxin C1 Exposure Induces Soluble Factor-Mediated Immunosuppression by Bovine CD4 + and CD8 + T Cells
KS Seo, SU Lee, YH Park, WC Davis, LK Fox, GA Bohach
Infection and immunity 2007
Regulatory T cells in patients with systemic lupus erythematosus
B Alvarado-Sánchez, B Hernández-Castro, D Portales-Pérez, L Baranda, E Layseca-Espinosa, C Abud-Mendoza, AC Cubillas-Tejeda, R González-Amaro
Journal of Autoimmunity 2006
Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis
Y Okuda, BR Apatoff, DN Posnett
Journal of Neuroimmunology 2006
CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-β treatment
J Jensen, AR Langkilde, JL Frederiksen, F Sellebjerg
Journal of Neuroimmunology 2006
Multiple Sclerosis — The Plaque and Its Pathogenesis
EM Frohman, MK Racke, CS Raine
New England Journal of Medicine 2006
Glatiramer acetate-specific human CD8+ T cells: Increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment
A Dressel, A Vogelgesang, H Brinkmeier, M Mäder, F Weber
Journal of Neuroimmunology 2006
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis
DK Tennakoon, RS Mehta, SB Ortega, V Bhoj, MK Racke, NJ Karandikar
Journal of immunology (Baltimore, Md. : 1950) 2006
Functional and phenotypic characterization of CD8+CD28+ and CD28− T cells in atopic individuals sensitized to Dermatophagoides pteronyssinus
O Lourenço, AM Fonseca, A Paiva, FA Arosa, L Taborda-Barata
Allergologia et Immunopathologia 2006
Endocrine Regulation of Suppressor Lymphocytes: Role of the Glucocorticoid-Induced TNF-Like Receptor
S Negrini
Annals of the New York Academy of Sciences 2006
Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
MA Friese, L Fugger
Brain 2005
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation
G Filaci, M Rizzi, M Setti, D Fenoglio, M Fravega, M Basso, G Ansaldo, P Ceppa, G Borgonovo, G Murdaca, F Ferrera, A Picciotto, R Fiocca, G Torre, F Indiveri
Annals of the New York Academy of Sciences 2005
Regulatory T Cells in Autoimmune Diseases: Anti-Ergotypic T Cells
A Mimran, IR Cohen
International Reviews of Immunology 2005
Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis
I Tsunoda, JE Libbey, LQ Kuang, EJ Terry, RS Fujinami
The American Journal of Pathology 2005
The activation of memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis
Y Okuda, M Okuda, BR Apatoff, DN Posnett
Journal of the Neurological Sciences 2005
T cell targeted immunotherapy for autoimmune disease
E Lee, AA Sinha
Autoimmunity 2005
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
MP Crawford, SX Yan, SB Ortega, RS Mehta, RE Hewitt, DA Price, P Stastny, DC Douek, RA Koup, MK Racke, NJ Karandikar
Blood 2004
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28− T cells and inhibit both T-Cell proliferation and CTL function
G Filaci, M Fravega, S Negrini, F Procopio, D Fenoglio, M Rizzi, S Brenci, P Contini, D Olive, M Ghio, M Setti, RS Accolla, F Puppo, F Indiveri
Human Immunology 2004
Role of cytokines in the pathogenesis of autoimmune diabetes mellitus.
Rabinovitch A, Suarez-Pinzon WL
Reviews in endocrine & metabolic disorders 2003
Cytokines and Chemokines in Autoimmune Disease
P Santamaria
2003
Glatiramer acetate (Copaxone) therapy Induces CD8+ T cell responses in patients with Multiple Sclerosis
Nitin J. Karandikar, Michael P. Crawford, Robert B. Ratts, Jason M. Brenchley, David R. Ambrozak, Amy E. Lovett-Racke, Elliot M. Frohman, Peter Stastny, Daniel C. Douek, Richard A. Koup, Michael K. Racke
Journal of Clinical Investigation 2002
Chemokine receptors associated with immunity within and outside the central nervous system in early relapsing–remitting multiple sclerosis
HY Wang, M Matsui, S Araya, N Onai, K Matsushima, T Saida
Journal of Neuroimmunology 2002
Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans
MV Dhodapkar, RM Steinman
Blood 2002
Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells
M Allez, J Brimnes, I Dotan, L Mayer
Gastroenterology 2002
Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis
H Ochi, XM Wu, M Osoegawa, I Horiuchi, M Minohara, H Murai, Y Ohyagi, H Furuya, J Kira
Journal of Neuroimmunology 2001
Tacrolimus, but not Cyclosporine A, significantly increases expression of ICAM-1 and IFN-? in the NOD mouse
G Papaccio, MV Latronico, A Graziano, A Lanza, M Pedull
Journal of Cellular Biochemistry 2001
Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease
J Killestein, BF Drijver, WL van der Graaff, BM Uitdehaag, CH Polman, RA van Lier
Multiple sclerosis (Houndmills, Basingstoke, England) 2001
Interleukin-12 Receptor/STAT4 Signaling Is Required for the Development of Autoimmune Myocarditis in Mice by an Interferon-γ–Independent Pathway
M Afanasyeva, Y Wang, Z Kaya, EA Stafford, KM Dohmen, AA Akha, NR Rose
Circulation 2001
Impairment of CD8 + T Suppressor Cell Function in Patients with Active Systemic Lupus Erythematosus
G Filaci, S Bacilieri, M Fravega, M Monetti, P Contini, M Ghio, M Setti, F Puppo, F Indiveri
Journal of immunology (Baltimore, Md. : 1950) 2001
Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+ and the CD8+ subsets
E Wallstrom, M Khademi, M Andersson, T Olsson
European Journal of Neurology 2000
Interferon-? secretion by peripheral blood T-cell subsets in multiple sclerosis: Correlation with disease phase and interferon-? therapy
B Becher, PS Giacomini, D Pelletier, E McCrea, A Prat, JP Antel
Annals of Neurology 1999
Lymphocyte migration and multiple sclerosis: Relation with disease course and therapy
A Prat, A Al-Asmi, P Duquette, JP Antel
Annals of Neurology 1999
Disproportionate Recruitment of CD8+ T Cells into the Central Nervous System by Professional Antigen-Presenting Cells
MJ Carson, CR Reilly, JG Sutcliffe, D Lo
The American Journal of Pathology 1999
Autoimmunity Is a Type I Interferon-Deficiency Syndrome Corrected by Ingested Type I IFN via the GALT System
SA Brod
Journal of Interferon & Cytokine Research 1999
Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis
SJ Khoury, EJ Orav, CR Guttmann, R Kikinis, FA Jolesz, HL Weiner
Neurology 1999
A dimeric form of soluble recombinant sheep LFA-3(CD58) inhibits human T-cell proliferation by generating regulatory T cells
K Yamashita, T Kakutani, T Ohashi, T Saibara
Immunopharmacology 1997
Inhibition of the Progression of Multiple Sclerosis by Linomide Is Associated with Upregulation of CD4+/CD45RA+Cells and Downregulation of CD4+/CD45RO+Cells
D Lehmann, D Karussis, R Mizrachi-Koll, AS Linde, O Abramsky
Clinical Immunology and Immunopathology 1997
CD27/CD70 Interaction Contributes to the Activation and the Function of Human Autoreactive CD27+Regulatory T Cells
S Jacquot, T Kobata, S Iwata, SF Schlossman, C Morimoto
Cellular Immunology 1997
Human CD8+ TCR-αβ+ and TCR-γδ+ cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms
J Correale, M Rojany, LP Weiner
Journal of Neuroimmunology 1997
Increased in Vitro Induced CD4+ and Cd8+ T Cell Ifn-GM and CD4+ T Cell Il-10 Production in Stable Relapsing Multiple Sclerosis
SA Brod, LD Nelson, M Khan, JS Wolinsky
International Journal of Neuroscience 1997
Interferon-γ confers resistance to experimental allergic encephalomyelitis
M Krakowski, T Owens
European Journal of Immunology 1996
Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-γ
H Heremans, C Dillen, M Groenen, E Martens, A Billiau
European Journal of Immunology 1996

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 1 X users
34 readers on Mendeley
See more details